Анализ закономерностей экспрессии генов, ассоциированной с прогрессией гепатокарцином
Диссертация
Гепатоцеллюлярная карцинома (ГК) — одна из наиболее распространенных форм опухолей, возникающая из основных клеток печени, гепатоцитов. Факторами риска, способствующими развитию этого заболевания, являются хронические вирусные инфекции (вирусы гепатита В и С), цирроз печени, хронические алкогольные отравления, воздействие химических гепатоканцерогенов. Исследование генетических нарушений, а также… Читать ещё >
Список литературы
- Абелев Г. И. (1998) Альфа-фетопротеин взгляд в биологию развития и природу опухолей. Соросовский образовательный журнал, 9, 8−14.
- Базин И.С. (2008) Гепатоцеллюлярный рак современное состояние проблемы. Практическая онкология, 9(4), 216−228.
- Гарин A.M., Базин И. С. (2006) Первичный рак печени. Десять наиболее распространенных злокачественных опухолей, 4, 197−220.
- Канцерогенез, п. ред. Заридзе Д. Г., М.: Медицина, 2004.
- Кудрявцева Е.И., Морозова О. В., Рудинская Т. Д., Энгельгардт Н. В. (2001) Нарушение межклеточных контактов и взаимодействия клеток с внеклеточным матриксом в быстрорастущей гепатокарциноме мышей. Архив Патологии, 4, 33−37.
- Лазаревич Н.Л. (2003) Эпителиально-мезенхимальный переход при прогрессии гепатокарцином. Вестник РОНЦ РАМН, 3, 76−82.
- Лазаревич Н.Л. (2003) Изменения спектров экспрессии генов при гепатоканцерогенезе и прогрессии опухолей печени. Автореферат диссертации на соискание ученой степени доктора биологических наук, Москва, МГУ.
- Лазаревич, Н.Л. (2004) Молекулярные механизмы прогрессии опухолей печени. Успехи биологической химии, 44, 365−418.
- Лазаревич Н.Л., Флейшман Д. И. (2008) Ткане-специфические транскрипционные факторы в прогрессии эпителиальных опухолей. Биохимия, 73, 713−734.
- Липченко В.Я., Самусев Р. П. (1988) Атлас нормальной анатомии человека. М., Медицина.
- Лужников Е.А. (1999) Клиническая токсикология. М. Медицина. Марри Р. (1993) Биохимия человека, М., Мир.
- Рудинская Т.Д., Куприна Н. И., Лазаревич Н. Л., Полянская М. И., Полторанина B.C., Шавочкина Д. А., Энгельгардт Н. В. (2010) Частичная реверсия фенотипа низкодифференцированной гепатокарциномы в трехмерной культуре. Онтогенез, 41(1), 58−65.
- Флейшман Д.И., Морозова О. В., Лазаревич Н. Л. (2008) Сравнительная характеристика гепатокарцином мыши с различной степенью дифференцировки. Вестик Российского онкологического Научного центра им. Н. Н. Блохина РАМН, 2, 19−23.
- Флейшман Д.И. (2008) Автореферат диссертации на соискание ученой степени кандидата биологических наук, Москва, РОНЦ им.Н. Н. Блохина.
- Ченцов, Ю.С. (2004) Введение в клеточную биологию: учебник для вузов. М., ИКЦ Академкнига, с. 201−210.
- Abelev G.I., Eraiser T.L. (1999) Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin Cancer Biol., 9, 95−107.
- Abelev G.I., Lazarevich N.L. (2006) Control of differentiation in progression of epithelial tumors. Adv. Cancer Res., 95, 61−113.
- Alvaro D., Mancino M.G. (2007) New insights on the molecular and cell biology of human cholangiopathies. Mol Aspects Med, 29, 50−57.
- Ang SL, Wierda A, Wong D, Stevens KA, Cascio S, Rossant J, Zaret KS (1993) The formation and maintenance of the definitive endoderm lineage in the mouse: involvement of HNF3/forkhead proteins. Development, 119(4), 1301−1315
- Ashkenazi A., Dixit V.M. (1998) Death receptors: signaling and modulation. Science, 281, 13 051 308.
- Bazzoni G. (2003) The JAM family of junctional adhesion molecules. Curr. Opin. Cell Biol., 15, 525−530.
- Beyer E.C., Willecke K. (2000) Gap junction genes and their regulation. Adv. Mol. Cell Biol., 30, 1−30.
- Bertolino E., Reimund B., Wildt-Perinic D., Clerc R. (1995). A novel homeobox protein which recognizes a TGT core and functionally interferes with a retinoid-responsive motif. J. Biol. Chern., 270,31 178−31 188
- Bissell D. M, Roulot D., George J. (2001) Transforming growth factor beta and the liver. Hepatology, 34, 859−867.
- Boyer B., Valle’s A.M., Edme N. (2000) Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol., 60, 1091−1099.
- BuendiaM.A. (2000) Genetics of hepatocellular carcinoma. Cane. Biol., 10, 185−200.
- Carver E.A., Jiang R., Lan Y., Oram K. F, Gridley T. (2001) The Mouse Snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol. Cell. Biol., 21, 8184−8188.
- Chao D.T., Korsmeyer, S.J. (1998) BCL-2 family: regulators of cell death. Ann. Rev. Immunol., 16, 395−419.
- Chen F., Ogawa K., Nagarajan R.P., Zhang M., Kuang Ch., Chen Y. (2003) Regulation of TG-interacting factor by transforming growth factor-beta. Biochem J., 371, 257—263.
- Chiba H., Itoh T., Satohisa S., Sakai N., Noguchi H., Osanai M., Kojima T., Sawada N. (2005) Activation of p21CIPl/WAF/l gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4a. Exp. Cell Res., 302, 11−21.
- Ciardiello F., Tortora G. (2008) EGFR Antagonists in Cancer Treatment. N. Engl. J. Med., 358, 1160−1174.
- Cicchini C., Filipini D., Marchetti A., Cavallari C., Laudadio L., Spagnoli F.M., Alnozi T., Tripodi M. (2006) Snail controls differentiation of hepatocytes by repressing HNF4alpha expression. J. Cell Pysiol., 209, 230−238.
- Clotman F., Lannoy V., Reber M., Cereghini S., Cassiman D., Jacquemin P., Roskams T., Rousseau G.G., Lemaigre F.P. (2002) The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development, 129, 1819−1828.
- Coffinier C., Gresh L., Fiette L., Tronche F., Schutz G., Babinet C., Pontoglio M., Yaniv M., Barra J. (2002) Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNFlbeta. Development, 129, 1829−1838.
- Cordenonsi M., Dupont S., Maretto S., Insinga A., Imbriano C., Piccolo S. (2003) Links between tumor suppressors: p53 is required for TGF-? gene responses by cooperating with Smads. Cell, 113,301−314.
- Costa R.H., Kalinichenko V.V., Holterman Ai-X.L., Wang X. (2003) Transcription factors in liver development, differentiation, and regeneration. Hepatology, 38, 1331—1347.
- Coultas L., Strasser A. (2003) The role of the Bcl-2 protein family in cancer. Semin Cancer Biol., 13, 115−123.
- Datto M., Wang X.-F. (2000) The Smads: transcriptional regulation and mouse models. Cytokine Growth Factor Rev., 11, 37−48.
- Debatin K.-M, Stahnke K., Fulda S. (2003) Apoptosis in hematological disorders. Semin. Cancer Biol., 13,149−158.
- DeMali K.A., Wennerberg K., Burridge K. (2003) Integrin signaling to the actin cytoskeleton. Curr. Opin. Cell Biol., 15, 572−582.
- Demarchi F., Verardo R., Varnum B., Brancolini C., Schneider C. (2001) Gas6 anti-apoptotic signaling requires NF-kappa B activation. J. Biol. Chem., 276(34), 31 738−31 744.
- De Simone V., De Magistris L., Lazzaro D., Gerstner J., Monaci P., Nicosia A., Cortese R. (1991) LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J., 10,1435−1443.
- Devogdt N., Gkassabeh, G.H., Zhang J., Brys L., De Baetselier P., Revets H. (2003) Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci U.S.A., 100, 5778−5782.
- Donaldson J.G. (2003) Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J. Biol. Chem., 278, 41 543−41 576.
- Drewes T., Senkel S., Holewa B., Ryffel G.U. (1996) Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol. Cell/ Biol., 16, 925 931.
- Duncan S. A, Navas M. A, Dufort D., Rossant J., Stoffel M. (1998) Regulation of a transcription factor network required for differentiation and metabolism. Science, 281(5377), 692−695
- Duncan S.A., Nagy A., Chan W. (1997) Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4(-/-) embryos. Development, 124, 279−287.
- Evert M., Ott T., Temme A., Willecke K., Dombrowski F. (2002) Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin 32 deficient mice. Carcinogenesis, 23, 697−703.
- Engel M.E., McDonnell M.A., Law B.K., Moses H.L. (1999) Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J. Biol. Chem., 274, 3 741 337 420.
- Farazi P. A, DePinho R.A. (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer, 6, 674−687.
- FaustoN. (2000) Liver regeneration. J. Hepatology, 31,19−31.
- Finberg N., Silins I., Stenius U., Hogberg J. (2004) Characterizing the role of MDM2 in dietylnitrosamine induced acute liver damage and development of preneoplastic lesions. Carcinogenesis, 25, 113−122.
- Fisher A.N.M., Herrera B., Mikula M., Proell V., Fuchs E., Gotzman J., Schulte-Hermann R., Beug H., Mikulits W. (2005) Integration of Ras subeffector signaling in TGF-P mediated late stage hepatocarcinogenesis. Carcinogenesis, 26, 931−945.
- Folkman J. (2003) Angiogenesis and apoptosis. Semin. Cancer Biol., 13,159−167.
- Friedl P., Wolf K. (2003) Tumor-cell invasion and migration: diversity and escape mechanisms. Nature, 3, 392−405.
- Friedman J.R., Kaestner K.H. (2006) The FoxA family of transcription factors in development and metabolism. Cell Mol. Life, 63,2317−2328.
- Friedman J.R., Larris B.L., Le P. P, Peiris T.H., Arsenlis A., Schug J., Tobias J.W., Kaestner K.H., Greenbaum L.E. (2004) Orthogonal analysis of C/EBPa targets in vivo during liver proliferation. Proc. Natl. Acad. Sci. USA, 101, 12 986−12 991.
- Fukata M., Nakagawa M., Kaibuchi .K. (2003) Roles of Rho-family GTPases in cell polarization and directional migration. Curr. Opin. Cell Biol., 15, 590−597.
- Fulda S., Meyer E., Debatin K.M. (2002) Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene, 21,2283−2294.
- Gaiddon C., Moorthy M.C., Prives C. (1999) Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J., 18, 5609−5621.
- Gat-Yablonski G., Shalitin S., Phillip M. (2007) Maturity onset diabetes of the young. Pediatr. Endocrinol. Rev., 3, 514−520.
- Gery S., Tanosaki S., Bose S., Bose N., Vadgama J., Koeffler H.P. (2005) Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Clin. Cancer Res., 11,3184−3190.
- Govinden R., Bhool K.D. (2003) Genealogy, expression, and cellular function of transforming growth factor-p. Pharmacol. Ther., 98, 257−265.
- Graveel C.R., Jatkoe T., Madore S.J., Holt A.L., Farnham P.J. (2001) Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene, 20, 2704−2712.
- Gustafsson A., Bostrom A.K., Ljungberg B., Axelson H., Dahlback B. (2009) Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma. PLoS One, 4, e7575: 1−10.
- Hafizi S., Dahlback B. (2006) Signaling and functional diversity within the Axl subfamily of receptor tyrosine kinase. Cytokine Growth Factor Rev, 17, 295−304.
- Hafner M., Schmitz A., Grune I., Srivatsan S.G., Paul B., Kolanaus W., Quast T., Kremmer E., Bauer I., Famulok M. (2006) Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature, 444, 941−944.
- Halin W.C., Weinberg R.A. (2000) The hallmarks of cancer. Cell, 100, 1593−1604.
- Halmos B., Huettner C.S., Kocher O., Ferenczi K., Karp D.D., Tenen D.G. (2002) Down-regulation and antiproliferative role of C/EBPalpha in lung cancer. Cancer Res., 62, 528−534.
- Hayashi Y., Wang W., Ninomiya T., Nagano H., Ohta K., Itoh H. (1999) Liver enriched transcription factors and differentiation of hepatocellular carcinoma. J. Clin. Pathol: Mol Pathol., 52, 19−24.
- Hennesy C., Porth C.M. (2002) In Essentials of Patophysiology, Academic press, London, pp. 494−517.
- Herrera B., Alvarez AM., Beltran J., Valdes F., Fabregat I., Fernandez M. (2004) Resistance to TGF-beta-induced apoptosis in regenerating hepatocytes. J. Cell Physiol., 201, 385−392.
- Hertz R., Sheena V., Kalderon B., Berman I., Tana J. (2001) Suppression of hepatocyte nuclear factor-4a by acyl-CoA thioesters of hypolipidemic peroxisome proliferators. Biochem. Pharmacol., 61, 1057−1062.
- Hildt E., Hofschneider P.H., Urban S. (1996) The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Sem. Virology, 7, 333−347.
- Hollander C., Nystrom M., Janciauskiene S., Westin U. (2003). Human mast cells decrease SLPI levels in type II like alveolar cell model, in vitro. Cancer Cell. Int., 3, 201−210.
- Hood J.D., Cheresh D.A. (2002) Role of integrins in cell invasion and migration. Nature Rev. Cancer, 2, 91−100.
- Home M.C., Goolsby G.L., Donaldson K.L., Tran D., Neubauer M., Wahl A.F. (1996) Cyclin G1 and Cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J. Biochem. Chem., 271, 6050−6061.
- Jacquemin P., Pierreux C.E., Fierens S., Van Eyll J.M., Lemaigre F., Rousseau G.G. (2003) Cloning and embryonic expression pattern of the mouse Onecut transcription factor OC-2. Gene Expr. Patterns, 3, 639−644.
- Jakob R., Heine M., Eikemeyer J., Fuker N., Zimmer K.-P., Reshaer U., Gerke V., Nairn H.Y. (2004) Annexin II is required for apical transert in polarized epithelial cells. J. Biol.Chem., 279, 3680−3684.
- Jover R., Bort R., Gomez-Lechon M. J., Castel J.V. (1998) Re-expression of C/EBPa induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett., 431, 227−230.
- Kajita M., McClinic K.N., Wade P.A. (2004) Aberrant Expression of the Transcription Factors Snail and Slug Alters the Response to Genotoxic Stress. Mol. Cell. Biol., 24, 7559−7566.
- Kanzler S., Galle P.R. (2000) Apoptosis in the liver. Semin. Cancer. Biol., 10,173−184.
- Kern M.A., Breuhahn K., Sclirimacher P. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Cancer Res., 86, 67−113.
- H.S., Shome K., Rojas R., Rizzo M.A., Vasudevan C., Fluharty E., Santy L.C., Casanova J.E., Romero G. (2003) The Guanine Nucleotide Exchange Factor ARNO mediates the activation of ARF and phospholipase D by insulin. BMC Cell Biol., 11, 4−13.
- Z., Ghosh S., Wang Z., Hunter H. (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of p-catenin, and enhanced tumor cell invasion. Cancer Cell, 4, 499−516.
- Magenheim J., Hertz R., Berman I., Nousbeck J., Bar-Tana J. (2005) Negative autoregulation of HNF-4alpha gene expression by HNF-4alphal. Biochem. J., 388, 325−332.
- Maire P., Wuarin J., Schibler U. (1989) The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science, 244, 343−346.
- Malliri A., Collardy J.G. (2003) Role of Rho-family proteins in cell adhesion and cancer Curr. Opin. Cell Biol., 15, 583−589.
- Manabe R., Ohe N., Maeda T., Fukuda T., Sekiguchi K. (1997) Modulation of cell-adhesive activity of fibrinectin by the alternatively spliced EDA segment. J. Cell Biol., 139, 295−307.
- Marten N.W., Hsiang C.-H., Yu L., Stollenwerk N.S., Straus D.S. (1999) Functional activity of hepatocyte nuclear factor-1 is specially decreased in amino acid-limited hepatoma cells. Biochim. Biophys. Acta, 1447, 160−174.
- Massague J. (1998) TGF-beta signal transduction. Annu Rev Biochem, 67, 753−791. Massague J., Chen Y.G. (2000) Controlling TGF-P signaling. Genes Dev., 14, 627−644.
- McCune B.K., Earp H.S. (1989) The epidermal growth factor receptor tyrosine kinase in liver epithelial cells. J. Biol. Chem., 264,15 501−15 507.
- Meda P.C., Spray D.C. (2000) Gap junction function. Adv. Mol. Cell. Biol., 30,263−322.
- Miller J.R., Quing J., Derynck K. (2002) In The cancer handbook (Alison, R.A. ed.) Nature, 179 208.
- Miyazono K. (2000) TGF-p signaling by Smad proteins. Cytokine Growth Factor Rev., 11, 1522.
- Moreno M., Molina H., Amigo L., Zanlungo S., Arrese M., Attilio Rigotti A., Miquel J.F. (2003) Hepatic overexpression of caveolins increases bile salt secretion in mice. Hepatology, 38, 14 781 490.
- Moss J., Vaughan M. (2002) Cytohesin-1 in 2001. Arch. Biochem. Biophys, 397, 156−161.
- Moustakas A., Pardali EC., Gaal A., Heldin C.-H. (2002) Mechanisms of TGF-p signaling in regulation of cell growth and differentiation. Immunology Lett., 82, 85−91.
- Moustakas A., Heldin C.H. (2005) Non-Smad TGF-beta signals. J, Cell Sci., 118, 3573−3584.
- Nakamura T., Mura T., Saito K., Ohsawa T., Akiyoshi H., Kenzo S. (1998) Adenovirus-Transferred HNF-3y conserves some liver functions in primary cultured hepatocytes of adult rats. Biochem. Biophys. Res. Commun., 253, 352−357.
- Natarajan A., Wagner B., Sibilla M. (2007) The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. USA, 104, 17 081−17 086.
- Neveu M.J., Bertram J. (2000) Gap junctions during transformation neoplastic. Adv. Mol. Cell Biol., 30, 221−262.
- Oft M., Peli J., Rudaz C., Schwarz H., Beug H., Reichmann E. (1996) TGF-pi and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev., 10, 2462−2477.
- Ohta S., Shimekake Y., Nagata K. (1996) Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur. J. Biochem., 242, 460 466. T
- Okamoto T., Schelegels A., Scheker P.E., Lisanti M.P. (1998) Caveolins, a family of scaffolding proteins to organizing «preassembled signaling complexes» at the plasma membrane. J. Biol. Chem., 273, 5419−5422.
- Ott M. O., Rey-Campos J., Cereghini S., Yaniv M. (1991) vHNFl is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression. Mech. Dev., 36, 47−58.
- Ozdamar B., Bose R., Barrios-Rodiles M., Wang H. R., Zhang Y., Wrana J. L. (2005) Regulation of the polarity protein Par6 by TGFp receptors controls epithelial cell plasticity. Science, 307, 1603−1609.
- Parviz F., Matullo C., Garrison W.D., Savanski L., Adamson J.W., Ning G., Kaestner K.H., Rossi J.M., Zaret K.S., Duncan S.A. (2003) Hepatocyte nuclear factor 4a controls the development of a hepatic epithelium and morphogenesis. Nat. Genet., 34,292−296.
- Peinado H., Quintanilla M., Cano A. (2002) Transforming growth factor p-1 induces Snail transcription factor in epithelial cell lines. J.Biochem.Chem. 278,21 113−21 123.
- Peinado H., Ballestar E., Esteller M., Cano A. (2004) Snail mediates E-Cadherin repression by the recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex., Mol. Cell. Biol., 24, 306−319.
- Perlman R., Schiemann W.P., Brooks M.W., Lodish H.F., Weinberg R.A. (2001) TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol., 3, 708−714.
- Pontoglio M., Barra J., Hadchouel M., Doyen A., Kress C., Bach J. P., Babinet C., Yaniv M. (1996) Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell, 84, 575−585.
- Puisieux A., Ji J., Ozturk M. (1996) Annexin II up-regulates cellular levels of pll protein by a post-translational mechanisms. Biochem J., 313, 51−55.
- Rabe C., Cheng B., Coeselman W.H. (2001) Molecular mechanisms of hepatitis B virus associated liver cancer. Dig. Dis., 19, 279−287.
- Rafitery L.A., Sutherland D. J (1999) TGF-0 family signal transduction in Drosophila development: From Mad to Smads. Dev. Biol., 210,251−268.
- Rangaswami H., Bulbule A., Kundu G.C. (2005) JNK1 Differentially regulates osteopontin-induced Nuclear Factor-inducing Kinase/MEKKl-dependent Activating Protein-1-mediated promatrix Metalloproteinase-9 activation. J. Biol. Chem., 280,19 381−19 392.
- Rausa F.M., Galarneau L., Belanger L., Costa R.H. (1999) The nuclear receptor fetoprotein transcription factor is coexpressed with its target gene HNF-3 beta in the developing murine liver intestine and pancreas. Mech. Dev., 89, 185−188.
- Reichert M., Muller T., Hunziker W. (2000) The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby Canine Kidney I Cells. J. Biol. Chem., 275, 9492−9500.
- Reuber M.D. (1975) Histogenesis of hyperplasia and carcinomas of the liver arising around central veins in mice ingesting chlorinated hydrocarbons. Pathol. Microbiol., 43,287−298.
- Rocken C., McGrath S. (2001) Pathology and pathogenesis of hepatocellular carcinoma. Dig. Dis., 19,269−278.
- Ruse M.D. Jr., Privalsky, M.L., Sladek, F.M. (2002) Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4alphal: modulation by the F domain. Mol. Cell. Biol., 22, 1626−1638.
- Savagner P. (2001) Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchimal transition. Bioassays, 23, 912−923.
- Schiller M., Javelaud D., Mauviel A. (2004) TGF-p-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J. Dermatol. Sci., 10,1−10.
- Senkel S., Lucas B., Klein-Hitpass L., Ryffel G.U. (2005) Identification of target genes of the transcription factor HNFlbeta and HNF1 alpha in a human embryonic kidney cell line. Biochim. Biophys. Acta., 1731,179−190.
- Shibanuma M., Kuroki T., Nose K. (1992) Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. J. Biol. Chem., 267, 10 219−10 224.
- Shih D.Q., Heimesaat M, Kuwajima S., Stein R., Wright C.V., Stoffel M. (2002) Profound defects in pancreatic P-cell function in mice with combined heterozygous mutations in Pdx-1, HNF-la, and HNF-3p. Proc. Natl. Acad. Sci. USA, 99, 3818−3823.
- Shimizu S., Miyamoto Y., Hayashi M. (2002) Cell-type dependency of two Foxa/HNF3 sites in the regulation of vitronectin promoter activity. Biochim. Biophys. Acta, 1574, 337−344.
- Shimotohno K. (2000) Hepatitis C virus and its pathogenesis. Semin. Cancer Biol., 10, 233−240.
- Shiojiri N., Lemire J.M., Fausto N. (1991) Cell lineages and oval cell progenitors in rat liver development. Cancer Res., 51, 2611 -2620.
- Shostak K.O., Dmitrienko V.Y., Garifulin O.M., Rozumenko V.D., Khomenko O.V., Zozulya Y.A., Zehetner G., Kavsan V.M. (2003) Downregulation of putative tumor suppressor gene TSC-22 in human brain tumors. J. Surg. Oncol., 82, 57−64.
- Sladek F. M., Zhong W. M., Lai E., Darnell J. E. Jr. (1990) Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev., 4, 23 532 365.
- Smart E.J., Graf G.A., Mcniven M. A, Sessa W.C., Engelman J.A., Schrer P.E., Okamoto T., Lisanti M.P. (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol., 19,7289−7304.
- Spath G.F., Weiss M.C. (1998) Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J. Cel. Biol., 140, 935 946.
- Tang J., Zhou H.-W., Jiang J.-L., Yang X.-M., Li Y" Zhang H.-X., Chen Z.-N., Guo W.-P. (2009) pig-h3 interacts with alpha3betal integrin to promote adhesion and migration of human hepatoma cells. Exp. Biol. Med., 234, 35−39.
- Takafuji V., Forgues M., Unsworth E., Goldsmith P., Wang X.W. (2007) An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene, 26(44), 6361−6371.
- Tomoda T., Kudoh T., Noma T., Nakazawa A., Muramatsu M., Arai K. (1994) Molecular cloning of a mouse counterpart for human TGF-beta type I receptor. Biochem Biophys Res Commun., 198(3), 1054−62.
- Thiery J.P. (2002) Epithelial-mesenchymal transitions in tumor progression. Nature, 2, 442−454.
- Thorgeirsson S.S., Grisham, J.W. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet., 8, 339−345.
- Tomaru Y., Kondo S., Suzuki M.5 Hayashizaki Y. (2003) A comprehensive search for HNF-3a-regulated genes in mouse hepatoma cells by 60K cDNA microarray and chromatin immunoprecipitation / PCR analysis. Biochem. Biophys. Res. Commun., 310, 667−674.
- Torres-Padilla M.E., Fouge’re-Deschatrette C., Weiss M.C. (2001) Expression of HNF4a isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3'end splicing. Mech. Dev., 109, 183−193.
- Tronche F., Yaniv M. (1992) HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays, 14, 579−587.
- Vanhorenbeeck V., Jacquemin P., Lemaigre F., Guy G. Rousseau G.G. (2002) A novel mammalian member of the ONECUT class of transcription factors. Biochem. Biophys. Res. Commun, 292, 848−854.
- Vincent-Salomon A., Thiery J.P. (2002) Epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res., 5, 101−106.
- Volkert T.L., Schriber J., Rolfe P.A., Gifford D.K., Fraenkel E., Bell G.I., Young R.A. (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science, 303, 1378— 1381.
- Wang J. C, Stafford J. M, Granner D.K. (1998) SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J. Biol Chem., 273(47), 30 847−30 850.
- Wang D., Yamamoto S., Hijiya N., Benveniste E.N., Gladson C.L. (2000) Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene, 19, 5801−5809.
- Watt J., Garrison W.D., Duncan S.A. (2003) HNF4: a central regulator of hepatocyte differentiation and function. Hepatology, 37, 1249−1253.
- Whellock M., Johnson K.R. (2003) Cadherin-mediated cellular signaling. Curr. Opin. Cell Biol., 15, 509−514.
- Wogan G.W. (2000) Impacts of chemicals on liver cancer risk. Semin. Cancer Biol., 10, 201 210.
- Wotton D., Lo R.S., Swaby L.A., Massague J. (1999) Multiple modes of repression by the Smad transcriptional compressor TGIF. J. Biol. Chem., 274, 37 105−37 110.
- Xanthopoulus K.G., Mirkovitch J. (1993) Gene regulation in rodent hepatocytes during development, differentiation and disease. Eur. J. Biochem., 216, 353−60.
- Yamate J., Tajima M., Kudow S., Sannai S. (1990) Background pathology in BDF1 mice allowed to live out their life-span. Lab. Anim., 24, 332−340.
- Yi J. Y., Shin I., Arteaga C.L. (2005) Type I transforming growth factor P receptor binds to and activates phosphatidylinositol 3-kinase. J. Biol. Chem., 280, 10 870−10 876.
- Yue J., Mulder K.M. (2000) Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a smad-dependent pathway. J. Biol. Chem., 275, 30 765−30 773.
- Yungling J.M., Blanchard K.L., Sawer J.S. (2004) Development of TGF-p signalling inhibitors for cancer therapy. Nature, 3, 1011−1020.
- Zavadil J., Bottinger E. (2005) TGF-p and epithelial-to-mesenchymal transitions. Oncogene, 24, 5674−5774.
- Zezula J., Freissmuth M. (2008) The A(2A)-adenosine receptor: a GPCR with unique features? Br. J. Pharmacol., 153, 184−190.
- Zhao L., Samuels T., Winckler S., Korgaonkar C., Tompkins V., Home M.C., Quelle 1 D.E. (2003) Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol. Cancer Res., 1,195−206.
- Zhao R., Duncan S.A. (2005) Embryonic development of the liver. Hepatology, 41(5), 956−67.
- Zhivotovsky B., Orrenius S. (2003) Defects in the apoptotic machinery of cancer cells: role in drug resistance. Semin. Cancer Biol., 13,125−134.
- Zobiack N., Gerke V., Rescher U. (2001) Complex formation and submembranous localization of annexin 2 and S100A10 in liver HepG2 cells. FEBS Lett., 500, 137−140.